← FDA Drug Approvals (Drugs@FDA)

FULVESTRANT

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: XIROMED · Approved 2021-08-13

Drug application

FDA Application #

ANDA213553

Application type

Abbreviated New Drug Application (Generic)

Brand name

FULVESTRANT

Generic name

FULVESTRANT

Active ingredients

FULVESTRANT

Dosage form

SOLUTION

Route

INTRAMUSCULAR

Marketing status

Prescription

Sponsor

XIROMED

Manufacturer

Northstar Rx, LLC,

First approval

2021-08-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown